ABSTRACT
@#Dentin hypersensitivity is mainly associated with abrasion, wear, acid etching, cracking, wedge-shaped defects, enamel hypoplasia, caries, a lack of neck enamel, and cementum coverage accompanied by gingival recession, resulting in direct exposure of dentin tubules to the oral environment. Dentin hypersensitivity is mainly treated by sealing the exposed dentin tubules and reducing the excitability of the pulpal nerves. Laser therapy, as a safe, fast and convenient treatment measure, has achieved good results both alone and in combination with other medicines and has attracted increasing attention. This paper reviews the research progress in the treatment of dentin hypersensitivity using several common laser therapy mechanisms with parameter selections in various scopes of application. A review of the literature shows that the Nd:YAG laser has a strong penetrating power and a large thermal effect and can denature and coagulate proteins in dentin tubules in a very short time; while the CO2 laser causes little damage to the dental pulp and has an obvious immediate curative effect by high absorption of water molecules in hydroxyapatite and the dentin surface is melted and recrystallized; the Er:YAG laser has high water absorption and a large thermal effect and can block the tubules by evaporating the fluid in the tubules and depositing salts; Er, Cr:YSGG laser energy can be fully absorbed by hydroxyapatite and water and result in desensitization by cutting hard tissues and melting periodontal dentin of the tube simultaneously; The Ga-Al-As semiconductor laser and He:Ne laser are low energy. The laser dosage mainly changes the permeability of nerve fibers to potassium and sodium ions and depolarizes the nerve fibers, producing an analgesic effect. The combination of a laser with a desensitizer can improve the clinical efficacy of treating dentin hypersensitivity.
ABSTRACT
Objective To investigate the efficacy and the course of desensitization treatment in bronchial asthma with positive specific IgE to dust mite in children. Methods A total of 105 children with bronchial asthma with positive specific IgE to dermatophagoides farinae allergens were randomized into the observation group and the control group. Children in the control group were treated to continue anti-asthma according to the routine of prevention and treatment children with asthma. Chinldren in the observation group were treated by dermatophagoides farinae drops in addition to the treatment of children in the control group. The recurrence of asthma was compared between two groups at 25 weeks post-treatment. At 25 weeks post-treatment , children in the observation group was randomly divided into the observation groupⅠand group Ⅱ. Children in the observation groupⅠreceived continuous treatment except for desensitization treatment. Children in the observation group II received the sublingual immunotherapy with dermatophagoides farinae drops (No.4) for 1 year in addition to the treatment in the observation groupⅠ. The recurrence of asthma was also compared between the two sub-groups. Results The rate and times of recurrence of asthma were lower in the observation group than those in the control group(P 0.05). Conclusion The recurrent rate and frequency of asthma could be reduced by the sublingual immunotherapy with dermatophagoides farinae drops in children with asthma of positive specific IgE to dust mite. The course of treatment may be half year long.
ABSTRACT
OBJECTIVE: To report the clinical manifestations of one case systemic lupus erythematosus (SLE) complicated with Pneumocystis pneumonia(PCP), and the process that in accordance with the treatment guidelines of the patients who had a history of sulfa allergy in patients with sulfa desensitization program treatment. METHODS: Involved in the discussion of treatment of a patient in our hospitals intensive care unit who has systemic lupus erythematosus(SLE) complicated with Pneumocystis pneumonia(PCP) and history of sulfur allergy, and analyze the clinical data of the patient retrospectively. RESULTS: The middle-aged women suffering from systemic lupus erythematosus (systemic lupus erythematosus; SLE) combined Pneumocystis pneumonia (Pneumocystis pneumonia, PCP) infection. Due to her history of sulfa drug allergies, antibiotics and sulfa desensitization treatment were given. Symptoms were eased sputum smear PCP (negative). CONCLUSION: The infection is generally the main life-threatening reason to patients with autoimmune disease in clinical, taking a comprehensive treatment is a necessary measure for patients with SLE combined PCP for the patients who are allergic to Sulfa drugs with contraindications or undesirable effects using alternative drug. Desensitization treatment may be one of the choices for these patients. Copyright 2012 by the Chinese Pharmaceutical Association.